<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bruton's tyrosine kinase (BTK) is a member of the Src-related Tec family of protein tyrosine kinases </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in the btk gene have been linked to severe developmental blocks in human B-cell ontogeny leading to <z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:hpo ids='HP_0004432'>agammaglobulinemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we provide unique biochemical and genetic evidence that BTK is an inhibitor of the Fas/<z:chebi fb="16" ids="53704">APO</z:chebi>-1 <z:hpo ids='HP_0011420'>death</z:hpo>-inducing signaling complex in B-lineage lymphoid cells </plain></SENT>
<SENT sid="3" pm="."><plain>The Src homology 2, pleckstrin homology (PH), and kinase domains of BTK are <z:hpo ids='HP_0000001'>all</z:hpo> individually important and apparently indispensable, but not sufficient, for its function as a negative regulator of Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>BTK associates with Fas via its kinase and PH domains and prevents the FAS-FADD interaction, which is essential for the recruitment and activation of FLICE by Fas during the apoptotic signal </plain></SENT>
<SENT sid="5" pm="."><plain>Fas-resistant DT-40 <z:hpo ids='HP_0002665'>lymphoma</z:hpo> B-cells rendered BTK-deficient through targeted disruption of the btk gene by homologous recombination knockout underwent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> after Fas ligation, but <z:mp ids='MP_0002169'>wild-type</z:mp> DT-40 cells or BTK-deficient DT-40 cells reconstituted with <z:mp ids='MP_0002169'>wild-type</z:mp> human btk gene did not </plain></SENT>
<SENT sid="6" pm="."><plain>Introduction of an Src homology 2 domain, a PH domain, or a kinase domain mutant human btk gene into BTK-deficient cells did not restore the resistance to Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Introduction of <z:mp ids='MP_0002169'>wild-type</z:mp> BTK protein by electroporation rendered BTK-deficient DT-40 cells resistant to the apoptotic effects of Fas ligation </plain></SENT>
<SENT sid="8" pm="."><plain>BTK-deficient RAMOS-1 human Burkitt's <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells underwent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> after Fas ligation, whereas BTK-positive NALM-6-UM1 human B-cell precursor <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells expressing similar levels of Fas did not </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment of the anti-Fas-resistant NALM-6-UM1 cells with the <z:chebi fb="0" ids="6402">leflunomide</z:chebi> metabolite analog alpha-cyano-beta-<z:chebi fb="36" ids="29309">methyl</z:chebi>-beta-hydroxy-N-(2, 5-dibromophenyl)propenamide, a potent inhibitor of BTK, abrogated the BTK-Fas association without affecting the expression levels of BTK or Fas and rendered them sensitive to Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>The ability of BTK to inhibit the pro-apoptotic effects of Fas ligation prompts the hypothesis that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of developing B-cell precursors during <z:mpath ids='MPATH_458'>normal</z:mpath> B-cell ontogeny may be reciprocally regulated by Fas and BTK </plain></SENT>
</text></document>